These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 33368687)

  • 1. Serum ACE as a prognostic biomarker in COVID-19: a case series.
    Kolberg ES; Wickstrøm K; Tonby K; Dyrhol-Riise AM; Holten AR; Amundsen EK
    APMIS; 2021 Apr; 129(4):237-238. PubMed ID: 33368687
    [No Abstract]   [Full Text] [Related]  

  • 2. ACE2 Elevation in Severe COVID-19.
    Reindl-Schwaighofer R; Hödlmoser S; Eskandary F; Poglitsch M; Bonderman D; Strassl R; Aberle JH; Oberbauer R; Zoufaly A; Hecking M
    Am J Respir Crit Care Med; 2021 May; 203(9):1191-1196. PubMed ID: 33600742
    [No Abstract]   [Full Text] [Related]  

  • 3. The assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease.
    Avanoglu Guler A; Tombul N; Aysert Yıldız P; Özger HS; Hızel K; Gulbahar O; Tufan A; Erbaş G; Aygencel G; Guzel Tunçcan O; Dizbay M; Öztürk MA
    Scand J Clin Lab Invest; 2021 Apr; 81(2):160-165. PubMed ID: 33474994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019.
    Zhu Z; Cai T; Fan L; Lou K; Hua X; Huang Z; Gao G
    BMC Infect Dis; 2020 Nov; 20(1):883. PubMed ID: 33238910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19.
    Kornilov SA; Lucas I; Jade K; Dai CL; Lovejoy JC; Magis AT
    Crit Care; 2020 Jul; 24(1):452. PubMed ID: 32698840
    [No Abstract]   [Full Text] [Related]  

  • 6. Search for SARS-CoV-2 RNA in platelets from COVID-19 patients.
    Bury L; Camilloni B; Castronari R; Piselli E; Malvestiti M; Borghi M; KuchiBotla H; Falcinelli E; Petito E; Amato F; Paliani U; Vaudo G; Cerotto V; Gori F; Becattini C; De Robertis E; Lazzarini T; Castaldo G; Mencacci A; Gresele P
    Platelets; 2021 Feb; 32(2):284-287. PubMed ID: 33349108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for severe acute respiratory syndrome coronavirus 2 patients.
    Choi EY; Park HH; Kim H; Kim HN; Kim I; Jeon S; Kim W; Bae JS; Lee W
    Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 32859680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19.
    Haljasmägi L; Salumets A; Rumm AP; Jürgenson M; Krassohhina E; Remm A; Sein H; Kareinen L; Vapalahti O; Sironen T; Peterson H; Milani L; Tamm A; Hayday A; Kisand K; Peterson P
    Sci Rep; 2020 Nov; 10(1):20533. PubMed ID: 33239683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Volume in Vitro Diagnostic Proton NMR Spectroscopy of Human Blood Plasma for Lipoprotein and Metabolite Analysis: Application to SARS-CoV-2 Biomarkers.
    Lodge S; Nitschke P; Loo RL; Kimhofer T; Bong SH; Richards T; Begum S; Spraul M; Schaefer H; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2021 Feb; 20(2):1415-1423. PubMed ID: 33491459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum KL-6 concentrations as a novel biomarker of severe COVID-19.
    d'Alessandro M; Cameli P; Refini RM; Bergantini L; Alonzi V; Lanzarone N; Bennett D; Rana GD; Montagnani F; Scolletta S; Franchi F; Frediani B; Valente S; Mazzei MA; Bonella F; Bargagli E
    J Med Virol; 2020 Oct; 92(10):2216-2220. PubMed ID: 32470148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of diagnostic value of ferritin in patients with COVID-19.
    Szarpak L; Zaczynski A; Kosior D; Bialka S; Ladny JR; Gilis-Malinowska N; Smereka J; Kanczuga-Koda L; Gasecka A; Filipiak KJ; Jaguszewski MJ
    Cardiol J; 2020; 27(6):886-887. PubMed ID: 33346371
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2-associated encephalitis.
    Bodro M; Compta Y; Llansó L; Esteller D; Doncel-Moriano A; Mesa A; Rodríguez A; Sarto J; Martínez-Hernandez E; Vlagea A; Egri N; Filella X; Morales-Ruiz M; Yagüe J; Soriano Á; Graus F; García F;
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32611761
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases.
    Kappert K; Jahić A; Tauber R
    Biomarkers; 2020 Dec; 25(8):616-625. PubMed ID: 32700561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human recombinant soluble ACE2 in severe COVID-19.
    Zoufaly A; Poglitsch M; Aberle JH; Hoepler W; Seitz T; Traugott M; Grieb A; Pawelka E; Laferl H; Wenisch C; Neuhold S; Haider D; Stiasny K; Bergthaler A; Puchhammer-Stoeckl E; Mirazimi A; Montserrat N; Zhang H; Slutsky AS; Penninger JM
    Lancet Respir Med; 2020 Nov; 8(11):1154-1158. PubMed ID: 33131609
    [No Abstract]   [Full Text] [Related]  

  • 15. Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department.
    Nijhuis RHT; Russcher A; de Jong GJ; Jong E; Herder GJM; Remijn JA; Verweij SP
    J Clin Virol; 2020 Dec; 133():104655. PubMed ID: 33069846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19.
    Song KH; Kim DM; Lee H; Ham SY; Oh SM; Jeong H; Jung J; Kang CK; Park JY; Kang YM; Kim JY; Park JS; Park KU; Kim ES; Kim HB
    Korean J Intern Med; 2021 Jan; 36(1):11-14. PubMed ID: 32972123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 spillover events.
    Zhou P; Shi ZL
    Science; 2021 Jan; 371(6525):120-122. PubMed ID: 33414206
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019.
    Wu LX; Wang H; Gou D; Fu G; Wang J; Guo BQ
    J Clin Lab Anal; 2021 Jan; 35(1):e23649. PubMed ID: 33184940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 condition.
    Menezes SM; Jamoulle M; Carletto MP; Moens L; Meyts I; Maes P; Van Weyenbergh J
    Lancet Microbe; 2024 Aug; 5(8):100849. PubMed ID: 38677304
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum Ferritin is an independent risk factor for Acute Respiratory Distress Syndrome in COVID-19.
    Gandini O; Criniti A; Ballesio L; Giglio S; Galardo G; Gianni W; Santoro L; Angeloni A; Lubrano C
    J Infect; 2020 Dec; 81(6):979-997. PubMed ID: 32946917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.